Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06373237 · ClinicalTrials.gov registry record
Outcome of Embryos Transferred After Initial Chaotic Results on PGT-A
A clinical trial, sponsored by Inception Fertility Research Institute.
- Completed
- Registry status
- 600
- Enrollment target
NCT06373237: Completed study, sponsored by Inception Fertility Research Institute.
NCT06373237 is a clinical trial that has completed, run by Inception Fertility Research Institute. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06373237 has completed, sponsored by Inception Fertility Research Institute.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
This is a retrospective review of treatment outcomes from fertility clinics in The Prelude Network who have used Igenomix for PGT-A and have transferred embryos with initial chaotic results, regardless if re-biopsy was performed.
Primary Outcome
Frequency of re-biopsy post initial chaotic PGT-A result
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-03-26 |
| Est. Completion | 2025-04-28 |
What the finished NCT06373237 record still lists
NCT06373237 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06373237 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06373237 about?
NCT06373237 is a clinical study titled "Outcome of Embryos Transferred After Initial Chaotic Results on PGT-A". This is a retrospective review of treatment outcomes from fertility clinics in The Prelude Network who have used Igenomix for PGT-A and have transferred embryos with initial chaotic results, regardless if re-biopsy was performed.
What is the current status of trial NCT06373237?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2024-03-26. Estimated completion is 2025-04-28.
Who is sponsoring clinical trial NCT06373237?
This trial is sponsored by Inception Fertility Research Institute, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI